(Date:10/10/2008)...ILLE, PA The American Nurses Credentialing Center...MC) as a Magnet hospital. The news came via a conf... staff who broke out with cheers and applause., G...spitals and only 294 hospitals in the United Stat...00 hospitals are eligible for this recognition., ...
(Date:10/10/2008)...suggests poor self-care partly to blame , ... of Medicare beneficiaries who have diabetes, bein...e, according to a new study. , Publishing in ...nal Medicine , researchers from the University of ...average age of 75.6 years) who had diabetes and we...
(Date:10/10/2008)... Honoring excellence in the imp...he Healthcare Information and Management Systems S...8 Davies Awards in the Organizational, Ambulatory ... Chicago, IL (PRWEB) October...tion of electronic health records (EHRs), the Hea...
(Date:10/10/2008)...W YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins ... multimedia educational program,"Optimizing Adjuv...reatment,Selection," to present recent key researc...atment., In recent years, advancements in the tre...ic and biologic treatment combinations that are,in...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2(Date:10/8/2008)...d Scientists Expand Testing Using Cellular ...ND, Maine, Oct. 8 /- Wild Blueberry a...e of results from a new study,showing Wild Blueber...fruits like apples, bananas, red grapes and strawb...oxidant Activity (CAA) assay. New research,publish...
(Date:10/8/2008)...ws clinical improvement in patients with pulmonary...reatment options have limited benefit for this deb...blood vessel disease, -- Imatinib mesylate, ava... cancers, known to inhibit protein associated with...of imatinib mesylate in PAH in 2009 EAST HAN...
(Date:10/7/2008)...RNewswire/ -- The Texas Cardiac Arrhythmia,Institu...elected as one of,only a few sites in the nation t...r a new device to treat persistent atrial fibrilla...nd research center specializing in heart,rhythm di...cal Center and,Texas Cardiovascular Consultants., ...
(Date:10/7/2008)...ewswire-FirstCall/ -- CEL-SCI Corporation,(NYSE: ...aterial Transfer,Agreement (MTA) with the National...the laboratory of Dr. Francesco M. Marincola, M.D.... the tumor microenvironment,caused by CEL-SCI,s ca...,the Infectious Disease and Immunogentics Section,...
Breaking Medicine Technology:Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3Omega 3 intake during last months of pregnancy boosts an infant 26 23146 3Bs cognitive and motor development 16355 1Omega 3 intake during last months of pregnancy boosts an infant 26 23146 3Bs cognitive and motor development 16355 2International symposium explores fire suppression economics 2828 1International symposium explores fire suppression economics 2828 2Global Med Technologies 28R 29 Inc and Cerner Announce Strategic Alliance 16349 1Global Med Technologies 28R 29 Inc and Cerner Announce Strategic Alliance 16349 2Global Med Technologies 28R 29 Inc and Cerner Announce Strategic Alliance 16349 3Miami Hospital Market Sees Shift in Ownership of Two Area Facilities 16345 1Miami Hospital Market Sees Shift in Ownership of Two Area Facilities 16345 2...pound Could Be Utilized as an Adjuvant and Play Ke...COTTSDALE, Ariz., March 20, 2007 /PRNewswire-First...ubsidiary of IR,BioSciences Holdings, Inc. , annou...s Substance P analog, Homspera, suggests that the,...gent or vaccine,adjuvant. Studies performed in ani...
...lition for a Stronger FDA says drug review program...ewswire-USNewswire/ -- A new,estimate by the Alzhe...on Americans are living with Alzheimer,s disease -...a number that could more,than triple in the coming...oped for the debilitating illness. , The new numbe...
Other Medicine Technology:ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 2ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 3ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 4Alzheimer's Growth Shows Need for Increased FDA Funding 2Alzheimer's Growth Shows Need for Increased FDA Funding 3Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base.
Certified by an independent laboratory to meet Class 100 specifications of Federal Standard 209E. Ergonomic seat guarantees worker confort, reduces fatique and back injuries. Clean vinyl meets Class
Inquire
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in.
Medicine Products: